Vero Biotech Growth, Revenue, Number of Employees and Funding

Overview

Location:
Atlanta, GA USA
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Vero Biotech's estimated revenue is currently $15.4M per year.
  • Vero Biotech received $14.6M in venture funding in October 2013.
  • Vero Biotech's estimated revenue per employee is $205333

Employee Data

  • Vero Biotech has 75 Employees.
  • Vero Biotech grew their employee count by 32% last year.
  • Vero Biotech currently has 3 job openings.

Executive Contacts

NameTitle
Leigh DavisDirector, Supply Chain
Katie FisherSenior Laboratory Director
Jennifer MancusoVice President of Human Strategy
Michael GentileVice President of Medical Affairs
Tod ShultzChief Strategy & Business Officer
Namita KhannaExecutive Director Strategic Development
Marcia JohnsonVice President
Jason MolinariVice President Of New Product Development
Kim René JonesDirector Quality Engineering
Christian SupinaDirector of Quality Systems

What Is Vero Biotech?

Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

75

Number of Employees

$15.4M

Revenue (est)

3

Current Jobs

32%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Envision Commun...
$6.1M3629%
Avion Pharmaceu...
$22.1M12514%
Peachtree Biore...
$6.7M3723%
Premier Kids Ca...
$9.2M484%
Clearside BioMe...
$11.6M5727%$95.3M
S Phase
$7M4014%
Acella Pharmace...
$10.3M558%
Sebela Pharmace...
$22.7M1206%
Relief Pharmaci...
N/A1185%
Conisus LLC
$9.6M5413%

Vero Biotech News

3-Feb-19 - Lehigh alumni aim to change medicine forever

Lehigh alumni Rory Siegel, '18, and Liam Walsh, '17, are translating the skills gained as undergraduates to their work at Vero Biotech, where ...

5-Oct-18 - Vero Biotech Names Michael Gentile as Vice President of ...

ATLANTA, Oct. 5, 2018 /PRNewswire/ -- Vero Biotech LLC, a biopharmaceutical company focused on the design, development and ...

2-Apr-18 - Biopharma company Vero Biotech relocating HQ to Atlanta ...

Vero Biotech, formerly GeNO LLC, designs, develops, and commercializes inhaled nitric oxide products for patients with cardiopulmonary ...

Vero Biotech Funding

DateAmountRoundLead InvestorsReference
2013-10-08$14.6MUndisclosedArticle

Vero Biotech Executive Hires

DateNameTitleReference
2012-12-19Kurt DassePresidentArticle
2013-08-28Kurt A. DasseCEOArticle
2018-10-08Michael GentileVice President of Medical AffairsArticle